A phase 1, first-in-human, open label, dose escalation study of MGD007, a humanized gpA33 x CD3 DART molecule, in patients with relapsed/refractory metastatic colorectal carcinoma
JOURNAL OF CLINICAL ONCOLOGY
Authors: Powderly, John D.; Hurwitz, Herbert; Ryan, David P.; Laheru, Daniel A.; Pandya, Naimish B.; Lohr, Joanna; Moore, Paul A.; Bonvini, Ezio; Wigginton, Jon M.; Crocenzi, Todd S.
Abstract
CDH17, GPA33 and MS4A12: Three Intestine-Specific Cell Surface Proteins as Potential Diagnostic Tools or Therapeutic Targets
MODERN PATHOLOGY
Authors: Panarelli, N. C.; Yantiss, R. K.; Chiu, R.; Old, L. J.; Chen, Y-T
Abstract